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An ocular manifestation of a systemic disease is an eye condition that directly or indirectly results from a disease process originating from another part of the body. There are many diseases known to cause ocular or visual changes as a result of systemic disease. Diabetes, for example, is the leading cause of new cases of blindness in those aged 20-74, with ocular manifestations such as diabetic retinopathy and macular edema affecting up to 80% of those who have had the disease for 15 years or more. Other diseases such as acquired immunodeficiency syndrome (AIDS) and hypertension are commonly found to have associated ocular symptoms. Physicians need to consider that systemic disease can involve the eyes and it is important for ophthalmologists to understand that they may be the first to suggest a diagnosis due to underlying systemic disease. According to the quote "The eyes are the windows of the soul", ophthalmologists should view the eyes as not only windows of the soul but also a window to the physical state of the entire body.
Systemic hypertension is a major risk factor for the development of retinal vascular diseases including hypertensive retinopathy, retinal vein or artery occlusion, and embolic events. High blood pressure also increases the risk for the development and progression of diabetic retinopathy. Signs of hypertensive retinopathy are predictive of target-organ damage including cardiovascular and cerebrovascular diseases [1] . High blood pressure affects the heart, kidney, brain, large arteries, and also the eyes. Retinal, choroidal, Diabetic retinopathy is one of the common causes of blindness.
It is an ocular manifestation of diabetes, which affects up to 80 percent of all patients who have had diabetes for 20 years or more.
Diabetic macular edema is the most common cause of visual dimness in patients with diabetic retinopathy. Dr. Lee will discuss the challenges and current treatments to prevent the visual disturbance related to diabetic macular edema [2] .
Systemic lupus erythematosus (SLE) is an autoimmune disease
in which the body's immune system mistakenly attacks healthy tissue in many parts of the body. SLE is a potentially life-threatening multisystem disease that is commonly associated with ocular manifestations. The purpose of this review is to outline the ocular manifestations of SLE and treatments [3] . Ocular complications have been reported in up to one-third of patients with SLE. Ocular manifestations can be associated with significant morbidity and eye issues may play a role as a marker for systemic disease activity. Sarcoidosis is a granulomatous disease that can include ocular involvement, and although its incidence is relatively high, communication can be challenging during collaborative treatments owing to differences in terminology. It is also difficult for a nonophthalmologist to achieve understanding of the types of ophthalmologic complications and each of their characteristics. Thus, Dr.
Kim will present literature regarding ocular sarcoidosis that will give insight into this disease for ophthalmologists [5] . bital decompression to more innovative therapies targeting immune system or specific molecules involved in TO pathogenesis [8] .
Systemic infections that are caused by various types of pathogenic organisms can be spread to the eyes as well as to other solid organs. Bacteria, parasites, and viruses can invade the eyes via the bloodstream. Despite advances in the diagnosis and treatment of systemic infections, many patients still suffer from endogenous ocular infections; this is particularly due to an increase in the number of immunosuppressed patients such as those with human immunodeficiency virus infection, those who have had organ transplantations, and those being administered systemic chemotherapeutic and immune-modulating agents, which may increase the chance of eye involvement. Dr. Lee focused on the conditions that ophthalmologists encounter most often and that require cooperation with other medical specialists and clinical information about ocular manifestations associated with various systemic infections will be reviewed in this issue [9] . This issue did not cover all ocular manifestations of systemic diseases but, it includes the representative disorders resulting seri-
